-+ 0.00%
-+ 0.00%
-+ 0.00%

Oncternal Therapeutics Has Been Granted U.S. Patent Number 12,128,026 Titled "Selective Androgen Receptor Degrader Ligands And Methods Of Use Thereof (For The Treatment Of Prostate Cancer)"

Benzinga·10/29/2024 19:17:58
Listen to the news

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12128026).pn